Thursday, May 26, 2022 5:51:15 PM
Here is the tweet...
Published now: The outlook for $RVVTF Phase 3 CT for COVID-19 got a little brighter on Thursday as the FDA appears to be amenable to the company’s submitted request to change the trial’s primary endpoints to a ‘symptoms’ focus. A material step forward 👀https://t.co/4FDIrgWZee
— The Dales Report (@TheDalesReport) May 26, 2022
Pennystocks post from DeepSkyAsronaut here also...
https://www.reddit.com/r/pennystocks/comments/uycz6u/fda_guiding_revive_therapeutics_to_determine_new/?utm_medium=android_app&utm_source=share
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM